Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03088176
Title Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors West Cancer Center
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
West Cancer Center Germantown Tennessee 38138 United States Details
*Shaded cells indicate that there was no data available from for the field